Key result
TAV-in-TAV-in-TAV successfully restores valve function and maintains 1-year stability after treated endocarditis.
Why the study?
Technical challenges of transcatheter valve-in-valve procedures require tailored strategies, and a third TAVI after treated prosthetic valve endocarditis remains scarcely reported.
Case Report (n=1)
No
A third TAVI procedure (TAV-in-TAV-in-TAV) can be a feasible and durable option at 1-year follow-up for patients with prohibitive surgical risk, multiple degenerated transcatheter valves, and a history of successfully treated prosthetic valve endocarditis, provided meticulous CT-guided procedural planning is employed.
Answers are grounded in this paper and cite their sources.
Supports TAV-in-TAV-in-TAV feasibility in high-risk patients with treated endocarditis; hypothesis-generating and should not yet change practice.
Given the diverse technical challenges associated with transcatheter valve-in-transcatheter valve procedures, the treatment strategy for each clinical case must be tailored to the individual patient.We present the case of a man in his late 70s with a complex clinical history, including two prior transcatheter aortic valve implantation (TAVI) procedures and infective endocarditis, who later developed severe degeneration of the aortic prosthesis requiring a third transcatheter intervention.Initially treated with a Lotus valve in 2014, the patient underwent a TAV-in-TAV with an Evolut prosthesis in 2022, followed by endocarditis-related degeneration and severe restenosis. In 2024, a third prosthetic valve (Acurate neo2) was implanted using the TAV-in-TAV-in-TAV technique.With expanding indications for TAVI and increasing longevity among treated patients, complex multi-prosthesis interventions may become more frequent, highlighting the need for improved procedural planning, imaging strategies and long-term surveillance. At 1-year follow-up, the patient remains asymptomatic with preserved valve function.This case illustrates the feasibility of a third TAVI after treated prosthetic valve endocarditis, supported by CT-guided procedural planning and 1-year follow-up, which remains scarcely reported in the literature.
No takes yet. Share an insight, caveat, or question.
Merkulov et al. (2026) conducted a case report in Prosthetic valve dysfunction after treated infective endocarditis (n=1). TAV-in-TAV-in-TAV (Acurate neo2 prosthesis) was evaluated on Procedural success, prosthetic valve performance, and clinical stability at 1 year. A third transcatheter aortic valve implantation (TAV-in-TAV-in-TAV) successfully restored valve function and maintained clinical stability without recurrence of infection at 1-year follow-up in a patient with treated prosthetic valve endocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: